INVESTABOT
Equity Research
XNYS · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: HCA Healthcare earned $7.15 per diluted share in Q1 2026, up 10.9% from $6.45 a year ago, on revenue of $19.1B — a 4.3% increase from $18.3B in Q1 2025.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 0 unique sellers · 7 accumulating - 5 trimming - 2 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| August 26, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | OTHER | -7,769 | $429 | ~$3.3M |
| May 7, 2026 | Marks Mike A | EVP and CFO | GIFT | -3,336 | — | — |
| May 7, 2026 | Marks Mike A | EVP and CFO | GIFT | 3,336 | — | — |
| April 28, 2026 | Frist William R | — | GRANT | 809 | — | — |
| April 28, 2026 | Frist Thomas F Iii | — | GRANT | 1,041 | — | — |
| April 28, 2026 | Smith Andrea B | — | GRANT | 509 | — | — |
| April 28, 2026 | Riley Wayne Joseph | — | GRANT | 509 | — | — |
| April 28, 2026 | Michelson Michael W | — | GRANT | 925 | — | — |
| April 28, 2026 | Johnston Hugh F | — | GRANT | 809 | — | — |
| April 28, 2026 | Deparle Nancy Ann | — | GRANT | 509 | — | — |
| April 28, 2026 | Chidsey John | — | GRANT | 809 | — | — |
| February 18, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | SELL | -1,694 | $533 | ~$0.9M |
| February 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | OPTION_EXERCISE | 5,000 | $237 | ~$1.2M |
| February 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | TAX_WITHHOLD | -3,306 | $540 | ~$1.8M |
| February 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | OPTION_EXERCISE | -5,000 | — | — |
| February 11, 2026 | Wyatt Christopher F. | SVP & Controller | SELL | -4,000 | $505 | ~$2.0M |
| February 11, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | SELL | -4,010 | $503 | ~$2.0M |
| February 10, 2026 | Wyatt Christopher F. | SVP & Controller | GRANT | 3,350 | — | — |
| February 10, 2026 | Wyatt Christopher F. | SVP & Controller | TAX_WITHHOLD | -1,034 | $502 | ~$0.5M |
| February 10, 2026 | Rossitto Erica | SVP & Chief Nurse Executive | GRANT | 1,676 | — | — |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| September 11, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 14,716,173 | ~$6.9B | — | January 29, 2026 |
| BlackRock | 13,363,266 | ~$6.3B | 6.2% | May 13, 2026 |
| BlackRock | 12,581,087 | ~$5.9B | — | February 12, 2026 |
| BlackRock | 13,003,600 | ~$5.1B | -2.7% | August 7, 2026 |
| BlackRock | 14,851,825 | ~$4.8B | — | August 13, 2024 |
| State Street | 7,539,550 | ~$3.6B | -0.4% | May 15, 2026 |
| State Street | 7,566,643 | ~$3.5B | — | February 13, 2026 |
| State Street | 7,469,035 | ~$2.9B | -0.9% | August 7, 2026 |
| Fidelity (FMR) | 4,401,023 | ~$2.1B | 14.8% | May 15, 2026 |
| Fidelity (FMR) | 3,833,373 | ~$1.8B | — | February 17, 2026 |
| JP Morgan Chase | 2,461,975 | ~$1.2B | 2.6% | May 13, 2026 |
| JP Morgan Chase | 2,399,220 | ~$1.1B | — | February 11, 2026 |
| Morgan Stanley | 2,294,880 | ~$1.1B | 4.6% | May 15, 2026 |
| Morgan Stanley | 2,194,522 | ~$1.0B | — | May 27, 2026 |
| Goldman Sachs | 2,139,172 | ~$1.0B | 20.7% | May 15, 2026 |
| Morgan Stanley | 2,586,771 | ~$1.0B | 12.7% | August 13, 2026 |
| Goldman Sachs | 2,467,414 | ~$962.0M | 15.3% | August 14, 2026 |
| JP Morgan Chase | 2,296,132 | ~$900.8M | -6.7% | August 12, 2026 |
| Goldman Sachs | 1,772,343 | ~$827.4M | — | March 25, 2026 |
| Fidelity (FMR) | 1,632,520 | ~$636.5M | -62.9% | August 13, 2026 |